VYNE Therapeutics (VYNE) Return on Capital Employed (QoQ) (2018 - 2025)
VYNE Therapeutics (VYNE) Return on Capital Employed (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -317.00 |
| Mar 31, 2025 | -1,515.00 |
| Dec 31, 2024 | -2,209.00 |
| Sep 30, 2024 | -1,498.00 |
| Jun 30, 2024 | -478.00 |
| Mar 31, 2024 | 2,238.00 |
| Dec 31, 2023 | 13,671.00 |
| Sep 30, 2023 | -5,297.00 |
| Jun 30, 2023 | -3,793.00 |
| Mar 31, 2023 | -380.00 |
| Dec 31, 2021 | -970.00 |
| Sep 30, 2021 | 1,708.00 |
| Jun 30, 2021 | 14,546.00 |
| Mar 31, 2021 | 9,727.00 |
| Dec 31, 2020 | -4,094.00 |
| Sep 30, 2020 | -5,854.00 |
| Jun 30, 2020 | -3,386.00 |
| Mar 31, 2020 | -2,553.00 |
| Dec 31, 2019 | -5,976.00 |
| Sep 30, 2019 | -2,033.00 |